Do you have the same question? Follow this Question
Jun 11, 2026 - 08:42 AM
We’ve provided several answers to questions related to Simponi (Golimumab) , see some other helpful Q&A related to this product.
Question: What is the chemical name of this medication?
Answer: The chemical name is recombinant human monoclonal antibody to tumor necrosis factor-alpha. Knowing the chemical name helps healthcare providers understand the drug’s mechanism of action.
Question: What is the active ingredient in this medicine?
Answer: The active ingredient is Golimumab, a monoclonal antibody that targets tumor necrosis factor-alpha (TNF-α). Targeting TNF-α helps control inflammation in autoimmune diseases.
Question: What are the routes of administration for this medication?
Answer: It can be given by subcutaneous (under the skin) or intravenous (into a vein) injection. Having both options allows for flexibility in how the medication is administered, accommodating patient preference and clinical needs.
Question: What is the bioavailability of this medication when given as a subcutaneous injection?
Answer: The bioavailability is 51% when administered subcutaneously, meaning just over half of the injected dose reaches the bloodstream. This is valuable for patients and prescribers to understand dosing and effectiveness.
